IQSEC1

Chr 3AR

IQ motif and Sec7 domain ArfGEF 1

Also known as: ARF-GEP100, ARFGEP100, BRAG2, GEP100, IDDSSBA

Predicted to enable protein kinase binding activity. Predicted to be involved in several processes, including positive regulation of focal adhesion disassembly; positive regulation of keratinocyte migration; and regulation of postsynaptic neurotransmitter receptor internalization. Located in centrosome; cytosol; and nucleoplasm. Implicated in intellectual developmental disorder with short stature and behavioral abnormalities and lung adenocarcinoma. Biomarker of lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.221 OMIM phenotype
Clinical SummaryIQSEC1
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ARLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
3 unique Pathogenic / Likely Pathogenic· 208 VUS of 293 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.22LOEUF
pLI 1.000
Z-score 5.34
OE 0.10 (0.050.22)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.28Z-score
OE missense 0.75 (0.700.81)
496 obs / 660.9 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.10 (0.050.22)
00.351.4
Missense OE?0.75 (0.700.81)
00.61.4
Synonymous OE?1.01
01.21.6
LoF obs/exp: 4 / 40.8Missense obs/exp: 496 / 660.9Syn Z: -0.11
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongIQSEC1-related intellectual disability, developmental delay, and short statureOTHERAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.4289th %ile
GOF
0.5169th %ile
LOF
0.71top 10%

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

293 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic2
VUS208
Likely Benign52
Benign9
Conflicting1
1
Pathogenic
2
Likely Pathogenic
208
VUS
52
Likely Benign
9
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
0
0
1
Likely Pathogenic
1
1
0
0
2
VUS
2
205
1
0
208
Likely Benign
0
8
3
41
52
Benign
0
4
1
4
9
Conflicting
1
Total3219545273

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

21 pathogenic / likely-pathogenic (of 25) ClinVar copy-number / structural variants overlap IQSEC1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

IQSEC1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →